15.84
Upstream Bio Inc Aktie (UPB) Neueste Nachrichten
Upstream Bio 2025 Q2 Earnings Net Loss Widens Despite Revenue Surge - AInvest
Upstream Bio, Inc. Reports Increased R&D Investments - TipRanks
Building trade automation scripts for Upstream Bio Inc.High Yield Watchlist with Filtered Picks - Newser
Upstream Bio (UPB) Q2 R&D Soars 169% - AOL.com
Is it too late to sell Upstream Bio Inc.Low Risk Strategy with Smart Entry Zones - Newser
Key resistance and support levels for Upstream Bio Inc.Free Swing Trade With Risk Management - Newser
Positive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments - TipRanks
Optimistic Buy Rating for Upstream Bio, Inc. Driven by Promising Lead Asset and Strong Execution - TipRanks
Upstream Bio's Q2 2025: Can a Robust Cash Position and TSLP Pipeline Sustain Investor Optimism Amid Rising Burn Rates? - AInvest
Upstream Bio Q2 Net Loss Narrows, Revenue Rises - MarketScreener
Upstream Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Upstream Bio's Strategic Momentum in TSLP Inhibition: A Pathway to Redefining Respiratory Disease Treatment? - AInvest
Earnings Flash (UPB) Upstream Bio Posts Q2 Net Loss $0.74 a Share, vs. FactSet Est of $0.61 Loss - MarketScreener
Upstream Bio reports Q2 revenue $937k, consensus $317k - TipRanks
Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress - GlobeNewswire
Tools to monitor Upstream Bio Inc. recovery probabilityFree Weekly Chart Analysis With Entry Advice - Newser
Real time social sentiment graph for Upstream Bio Inc.Summary of Consistent Growth Stock Picks - Newser
Comparing Upstream Bio Inc. in custom built stock radarsBear Market Safe Zone Technical Analysis - Newser
Analyzing net buyer seller activity in Upstream Bio Inc.Daily Technical Chart Pattern Analysis Report - Newser
Upstream Bio Inc. stock momentum explainedFree Price Action Based Buy Opportunity List - Newser
How to use a screener to detect Upstream Bio Inc. breakoutsProfit Target Planning with Exit Confidence - Newser
When is Upstream Bio Inc. stock expected to show significant growthUnbelievable profit margins - Jammu Links News
What are analysts’ price targets for Upstream Bio Inc. in the next 12 monthsCapitalize on emerging investment opportunities - Jammu Links News
What are Upstream Bio Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - Jammu Links News
Is Upstream Bio Inc. stock overvalued or undervaluedCapitalize on emerging market sectors - Jammu Links News
Upstream Bio (UPB) Expected to Announce Earnings on Tuesday - Defense World
Why is Upstream Bio Inc. stock attracting strong analyst attentionMaximize gains with data-driven stock picks - Jammu Links News
Should I hold or sell Upstream Bio Inc. stock in 2025Tremendous return on equity - Jammu Links News
How does Upstream Bio Inc. compare to its industry peersTrack stocks with high upside potential easily - Jammu Links News
Is it the right time to buy Upstream Bio Inc. stockConsistent high-performance stocks - Jammu Links News
What drives Upstream Bio Inc. stock priceDynamic profit expansion - Jammu Links News
What is the risk reward ratio of investing in Upstream Bio Inc. stockGet timely advice on market trends - Jammu Links News
How many analysts rate Upstream Bio Inc. as a “Buy”AI Powered Review For 2025 - Jammu Links News
Does Upstream Bio Inc. stock perform well during market downturnsBest Dividend Picks For 2025 - Jammu Links News
Upstream Bio, Inc. shares rise 7.97% premarket after Arkema reported resilient EBITDA margin and solid cash generation. - AInvest
Can swing trading help recover from Upstream Bio Inc. lossesWeekly Trend Screener with Momentum Picks - Newser
How to manage a losing position in Upstream Bio Inc.Strategy Chart for Real-Time Trade Flow - Newser
What makes Upstream Bio Inc. stock price move sharplyFree Pattern Detection for Entry Confirmation - Newser
Exit strategy if you’re trapped in Upstream Bio Inc.AI Trend Detection for Entry Timing - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):